Rotary Palm Ville & Sakra Hospital launch the Pink Express with the mission “Early Detection. Saves Lives”

IMT News Desk
IMT News Desk
· 3 min read
Pink Express, a mobile breast cancer screening centre equipped with breast cancer screening equipment (2)

Bangalore, June 29, 2019: At a high profile event today, organized by Rotary Bangalore Palmville, launched The Pink Express, a mobile breast cancer screening centre equipped with breast cancer screening equipment.  The event was attended by senior dignitaries from Rotary, Sakra World Hospital and the industry.

This is an initiative by Rotary Bangalore Palmville supported by Sakra World Hospital ( a leading Hospital in Bangalore). The Pink Express will be used for conducting awareness and screening camps for the underprivileged free of cost. While the Rotary is funding all the medical equipment for the Pink Express, Sakra Hospital is providing the doctors and medical technicians to conduct these camps. 

Speaking at the occasion, Mr Ritesh Goel ( President – Rotary Palmville) said “Rotary is involved with many community service based  projects involving Healthcare, Education, Environment and Vocational areas. Today, we are very happy to launch this initiative as a part of Rotary International’s global focus on Healthcare.  The technology being used in the Pink Express for screening is based on Thermal Imaging. This is a “No Touch No Pain” process encouraging more women to undergo this test and hence create a bigger social impact”

Mr Takashi Maki ( MD of Sakra World Hospital ) said “This initiative is in line with our philosophy of community services. We are very pleased to partner with Rotary who are committed to projects for a social cause. Breast Cancer is the biggest killer among women in India today. While in western countries the survival rates in Breast Cancer over the years has become progressively very high, sadly in India it is still woefully low. This is primarily due to lack of awareness and periodic screening as a result of which majority of the cases get detected in stage 3 or stage 4. This initiative is hence focused on Awareness Building and Early Detection leading to higher survival rates”

Added Mr Soumitro Ghosh ( Program Director- Rotary Palmville): “The Pink Express will travel to parts of Rural Bangalore, Karnataka and Tamil Nadu to do the camps. It is equipped with the Thermal Imaging equipment and an Ultrasonogram. The unique thing about the screening is the use of a new technology which is based on Thermal Imaging where heat maps of the breast are captured and subsequently interpreted by the system automatically aided by AI based Machine Learning software. The solution- Thermalytix is from Niramai, a Bangalore based company. Besides other benefits like a pain free process and no radiation hazards, this technology can detect abnormalities even below the age group of 40 years which is very relevant as India has a growing incidence rate of Breast Cancer in the younger population”

Read Next

Alembic Pharmaceuticals announces USFDA Tentative Approval for Darolutamide Tablets
News
May 14, 2026

Alembic Pharmaceuticals announces USFDA Tentative Approval for Darolutamide Tablets

Alembic Pharmaceuticals Limited (Alembic) has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Darolutamide Tablets, 300 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Nubeqa Tablets, 300 mg, of Bayer HealthCare Pharmaceuticals Inc. (Bayer). Darolutamide is an androgen […]
Article by: IMT News Desk
Lilly launches Lormalzi® (Donanemab) for the treatment of early symptomatic Alzheimer’s Disease in India
News
May 14, 2026

Lilly launches Lormalzi® (Donanemab) for the treatment of early symptomatic Alzheimer’s Disease in India

Eli Lilly and Company (India) Pvt. Ltd. has announced the launch of Lormalzi® (donanemab, 350 mg/20 mL IV vial) in India, following marketing authorisation from the Central Drugs Standard Control Organization (CDSCO) for the treatment of Alzheimer’s disease with mild cognitive impairment or those in the mild dementia stage of disease. Lormalzi® is the first […]
Article by: IMT News Desk
Stryker and Max Smart Hospital, Saket Partner to Advance Surgeon Training and Education in Robotic-Arm Assisted Joint Replacement
News
May 14, 2026

Stryker and Max Smart Hospital, Saket Partner to Advance Surgeon Training and Education in Robotic-Arm Assisted Joint Replacement

Stryker and Max Smart Super Speciality Hospital, Saket, announced a strategic collaboration to advance surgeon training, clinical education, and patient care in robotic-arm-assisted joint replacement in India. As part of this collaboration, Max Smart Super Speciality Hospital, Saket, will serve as a training and education center for orthopaedics. The collaboration aims to support the evolving joint replacement ecosystem […]
Article by: IMT News Desk
World’s First Subcutaneous Immunotherapy for Lung Cancer- Tecentriq® SC, now available in India
News
May 14, 2026

World’s First Subcutaneous Immunotherapy for Lung Cancer- Tecentriq® SC, now available in India

Roche Pharma India has launched Tecentriq® (atezolizumab) SC in India, the country’s first subcutaneous (under-the-skin) immunotherapy for lung cancer that can be administered in approximately 7 minutes, compared to conventional IV infusions that can take hours. By reducing treatment administration time to approximately 7 minutes, Tecentriq SC is a breakthrough innovation that has the potential […]
Article by: IMT News Desk